Molecular Partners AG
MOLN · SWISS
$3.67+$0.0608 (+1.68%)TodayMarket closed ·
Prev close $3.61
About MOLN
- Employees
- 134
- Headquarters
- Schlieren, Zuerich
- Listed
- Oct 22, 2014
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- molecularpartners.com
MOLN key statistics
- Market cap
- 122.34M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 1.66K
- Volume
- 4.31K
- Open price
- $3.67
- High today
- $3.76
- Low today
- $3.64
- 52 Week high
- $5.31
- 52 Week low
- $3.52
Molecular Partners AG (MOLN) at a glance
As of Oct 23, 2026, Molecular Partners AG (MOLN) shares are priced at $3.67, giving the company a market cap of 122.34M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $3.64 and $3.76. The current price is 0.8% above the day's low and 2.4% below its high.
Volume so far is 4.31K shares, above the average of 1.66K shares a day.
Over the past year Molecular Partners AG has ranged from $3.52 to $5.31, and now sits 8% of the way up that range.
Molecular Partners AG met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$0.3538 per share against an estimate of $0.00.
The average analyst price target is $12.95, 252.9% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
50%of 2 analyst ratings say Buy
- Buy50.0%
- Hold50.0%
- Sell0.0%
Price target · 7 analystsAvg $12.95
- Low
- $8.03
- Now
- $3.67
- High
- $19.27
MOLN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 28.6% on average.
- Q3 FY16: reported -$0.25 per share against an estimate of -$0.3162
- Q3 FY21: reported -$0.38 per share against an estimate of -$0.561
- Q4 FY23: reported -$0.6008 per share against an estimate of $0.00
- Q2 FY24: reported -$0.4323 per share against an estimate of $0.00
- Q4 FY24: reported -$0.3007 per share against an estimate of $0.00
- Q2 FY25: reported -$0.5406 per share against an estimate of $0.00
- Q4 FY25: reported -$0.234 per share against an estimate of -$0.3468
- Q2 FY26: reported -$0.3538 per share against an estimate of $0.00
MOLN news
12 Health Care Stocks Moving In Friday's Pre-Market Session
Similar companies
Companies in the same industry as Molecular Partners AG
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.